Lactulose Marel

Lactulose, the active ingredient in Lactulose Marel, is an osmotic laxative presented as an oral preparation for oral use. It is indicated for adult patients with chronic constipation and for individuals with liver disease at risk of encephalopathy, offering a non‑systemic therapeutic option.

GNH USA supplies Lactulose Marel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Lactulose is used as an osmotic laxative to treat conditions related to bowel motility and ammonia accumulation. - Constipation: softens stools and increases bowel movements, helping relieve chronic constipation. - Hepatic encephalopathy: reduces intestinal ammonia production, decreasing the risk of encephalopathic episodes in patients with liver disease. - Prevention of recurrent hepatic encephalopathy: maintains low ammonia levels to prevent relapse.

Lactulose may cause a range of adverse reactions, most of which are related to its osmotic activity in the gut.

Common Side Effects: - Abdominal bloating - Flatulence - Cramping - Diarrhea

Serious or Rare Side Effects: - Severe electrolyte imbalance - Dehydration - Allergic reactions (rash, urticaria)

Before initiating therapy, consider the following precautions. - Assess renal function: monitor patients with impaired kidney function for fluid and electrolyte balance. - Monitor electrolytes: check serum sodium and potassium during prolonged therapy. - Use caution in diabetes: lactulose may affect blood glucose control. - Avoid abrupt discontinuation: taper dose to prevent rebound constipation. - Adjust dose in hepatic impairment: start with lower dose and titrate. - Store at ambient temperature: keep in original container, protect from moisture.

Lactulose can interact with several drug classes; awareness helps prevent complications.

Major Interactions (Avoid): - Concurrent use with other laxatives: may cause excessive fluid loss and electrolyte disturbances. - Antidiarrheal agents (e.g., loperamide): can reduce lactulose efficacy and increase risk of constipation. - High-dose mineral supplements (e.g., calcium, magnesium): may interfere with lactulose’s osmotic action.

Moderate Interactions (Monitor Closely): - Antibiotics altering gut flora: may affect lactulose metabolism and efficacy. - Oral hypoglycemic agents: monitor blood glucose as lactulose can influence glucose absorption.